ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 154 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 2.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $180,361 | -10.9% | 286,287 | -8.2% | 0.03% | +92.9% |
| Q4 2022 | $202,502 | -62.3% | 311,974 | 0.0% | 0.01% | -80.6% |
| Q3 2022 | $537,000 | +329.6% | 311,974 | +209.8% | 0.07% | +500.0% |
| Q2 2022 | $125,000 | +35.9% | 100,715 | -28.7% | 0.01% | +71.4% |
| Q1 2022 | $92,000 | -40.3% | 141,254 | 0.0% | 0.01% | -56.2% |
| Q4 2021 | $154,000 | +18.5% | 141,254 | +413.5% | 0.02% | -11.1% |
| Q4 2019 | $130,000 | – | 27,506 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
| MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
| MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
| Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
| Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
| A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
| EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
| Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
| EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |